で公開中です！詳しく見る

Omnicell

OMCL

時価総額 $16.1億

35.39 USD

-0.56

1.56%

終値時点更新済み 10月16日 16:00 EDT

プレマーケット

時間外取引

35.25

-0.14

0.4%

1日

-1.56%

5日間

-1.34%

1か月

9.13%

3か月

-24.7%

6か月

-5.88%

年初来

-21.6%

1年

16.8%

5年間

-78.31%

10年間

-1.01%

概要： Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

従業員数： 3,485

ヘルスケア医療情報サービス

ニュース

ポジティブ

ニュートラル

ネガティブ

センチメント 3か月間

ポジティブ 44.4%

ニュートラル 50%

ネガティブ 5.6%

ポジティブ

Zacks Investment Research

Is This the Right Time to Retain Omnicell Stock in Your Portfolio?

OMCL raises its 2026 earnings outlook on cost discipline and efficiency, but rising memory costs and delayed Titan XT adoption pose challenges.

Is This the Right Time to Retain Omnicell Stock in Your Portfolio?

ニュートラル

Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026.

Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026

ポジティブ

Zacks Investment Research

Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?

ポジティブ

Zacks Investment Research

Here's Why Omnicell (OMCL) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Omnicell (OMCL) is a Strong Value Stock

ニュートラル

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

Integration brings serialized product verification and traceability directly into medication receiving workflows, intended to enable more efficient pharmacy operations without separate compliance processes. BOSTON, Sept.

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

ニュートラル

Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference.

Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference

ポジティブ

Zacks Investment Research

Why Omnicell (OMCL) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Omnicell (OMCL) is a Top Value Stock for the Long-Term

ニュートラル

The Motley Fool

Omnicell President Sells 6,753 Shares

The disposal comprised 6,753 shares representing a total transaction value of ~$250,000. The transaction reduced the insider's direct equity holdings by 4%.

Omnicell President Sells 6,753 Shares

ポジティブ

Zacks Investment Research

Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins

OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.

Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins

ネガティブ

Zacks Investment Research

OMCL Falls 20.1% in a Month as Booking and Margin Risks Build

Omnicell's 20.1% monthly slide reflects booking uncertainty, margin pressure and refresh-cycle risks despite a higher 2026 profit outlook.

OMCL Falls 20.1% in a Month as Booking and Margin Risks Build

ニュースランキングを見る

価格チャートは Lightweight Charts™ を使用して実装されています